Bollard Group’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-1,009
| Closed | -$7K | – | 429 |
|
|
2022
Q1 | $7K | Hold |
1,009
| – | – | ﹤0.01% | 412 |
|
|
2021
Q4 | $8K | Hold |
1,009
| – | – | ﹤0.01% | 417 |
|
|
2021
Q3 | $7K | Hold |
1,009
| – | – | ﹤0.01% | 413 |
|
|
2021
Q2 | $7K | Hold |
1,009
| – | – | ﹤0.01% | 411 |
|
|
2021
Q1 | $10K | Hold |
1,009
| – | – | ﹤0.01% | 412 |
|
|
2020
Q4 | $7K | Hold |
1,009
| – | – | ﹤0.01% | 413 |
|
|
2020
Q3 | $8K | Sell |
1,009
-3,186
| -76% | -$25.3K | ﹤0.01% | 413 |
|
|
2020
Q2 | $29K | Buy |
+4,195
| New | +$29K | ﹤0.01% | 391 |
|